The effect of pregnancy in humans on the pharmacokinetics of stable isotope labelled phenytoin.
Open accessThe DOI matches its Crossref record.
Abstract
1. To investigate the mechanism of the fall in steady‐state plasma phenytoin concentration relative to drug dose that occurs during pregnancy, single dose pharmacokinetic studies with stable isotope labelled phenytoin were carried out at different stages of pregnancy, and 2 to 4 months post‐natally, in five epileptic women receiving regular oral therapy with the drug. 2. Steady‐state apparent plasma clearances of phenytoin (dose/steady‐state concentration) correlated closely with simultaneous plasma clearances of the intravenous stable‐ isotope drug (measured as dose/AUC) suggesting that the patients were complaint with therapy when their phenytoin dosage requirement increased during the pregnancy, and that the oral drug was fully bioavailable. 3. In retrospect, two of the five subjects were probably studied too early post‐natally for phenytoin elimination kinetics to have returned to non‐pregnant values. Despite this, (i) the mean +/‐ s.d. t 1/2 for phenytoin was statistically significantly shorter in pregnancy than post‐natally (31 +/‐ 14 vs 39 +/‐ 28 h), (ii) the mean +/‐ s.d. whole plasma clearance was also statistically significant greater (0.025 +/‐ 0.012 vs 0.021 +/‐ 0.013 kg‐1 h‐1) and (iii) the mean +/‐ s.d. Vmax for phenytoin elimination was statistically significantly greater in pregnancy (1170 +/‐ 600 mg day‐1) than post‐ natally (780 +/‐ 470 mg day‐1). Although the mean +/‐ s.d. apparent Km was higher in pregnancy (18.2 +/‐ 8.4 mg l‐1, expressed in terms of whole plasma drug concentrations, compared with 10.2 +/‐ 7.4 mg l‐1 post‐natally), the difference was not statistically significant. However, if the apparent Km value was expressed in terms of plasma water phenytoin concentrations the difference (pregnant 2.50 +/‐ 0.85 mg l‐1: post‐natally 1.16 +/‐ 0.65 mg l‐1) was statistically significant. 4. Human pregnancy appears to result in an increased capacity to eliminate phenytoin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy
Tracy, T. S., Venkataramanan, R., Glover, D. D., & Caritis, S. N. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.08.030 · Cited by 448
Abduljalil, K., Furness, P., Johnson, T. N., Rostami-Hodjegan, A., & Soltani, H. (2012) · Clinical Pharmacokinetics · doi:10.2165/11597440-000000000-00000 · Cited by 371
“m CYP2C9 expression [CAR and PXR] Unknown m CL of CYP2C9 substrates: Phenytoin([262,263]) Glibenclamide (glyburide)([264])”
BackgroundJoining the DoTS: new approach to classifying adverse drug reactions
Aronson, J. K., & Ferner, R. E. (2003) · BMJ · doi:10.1136/bmj.327.7425.1222 · Cited by 297
Isoherranen, N., & Thummel, K. E. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.050245 · Cited by 239
“, 2005) (↑) CYP2C9 Phenytoin ↔ ↑ ↑ (Dickinson et al., 1989; Tomson et al., 1994) CYP3A4 Midazolam ↑ (Hebert et al.”
Harden, C. L., Pennell, P. B., Koppel, B. S., Hovinga, C. A., Gidal, B., Meador, K. J., Hopp, J., Ting, T. Y., Hauser, W. A., Thurman, D., et al. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02130.x · Cited by 170
“Three Class II studies (Lander et al., Epilepsia, 50(5):1247–1255, 2009 doi: 10.1111/j.1528-1167.2009.02130.x 1981; Bardy et al., 1987; Dickinson et al., 1989) also showed increased clearance and decreased levels during pregnancy.”
BackgroundInfluential
Metadata
- Authors
- Dickinson, R., Hooper, W., Wood, B., Lander, C., & Eadie, M.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 1989-07
- Volume
- 28
- Issue
- 1
- Pages
- 17-27
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W2054670071
- Cited by
- 38
- References
- 0
- FWCI
- 1.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effect of pregnancy in humans on the pharmacokinetics of stable isotope labelled phenytoin. https://app.cochat.ai/papers/10.1111/j.1365-2125.1989.tb03501.x
- The paper
- Dickinson, R., Hooper, W., Wood, B., Lander, C., & Eadie, M. (1989). The effect of pregnancy in humans on the pharmacokinetics of stable isotope labelled phenytoin. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.1989.tb03501.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.